He-bing Zhou
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control.
Journal: Cancer biology & therapy
Published: April 22, 2026
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.
Journal: Nature communications
Published: October 15, 2025
Retrospective Analysis of Venetoclax Combined with Azacitidine Compared with "3+7" or Similar Regimens for Newly Diagnosed Patients with Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: July 04, 2025
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory Study.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 28, 2024
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.
Journal: EClinicalMedicine
Published: September 13, 2023
MiR-203a-5p Inhibits Multiple Myeloma Cell Proliferation and Cell Cycle Progression via Targeting JAG1
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 25, 2023
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data.
Journal: British journal of haematology
Published: February 24, 2020
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma.
Journal: BioMed research international
Published: January 23, 2019
Last Updated: 09/26/2026